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Abstract
Background: Population-based administrative data have been used to study osteoporosis-related fracture risk
factors and outcomes, but there has been limited research about the validity of these data for ascertaining fracture
cases. The objectives of this study were to: (a) compare fracture incidence estimates from administrative data with
estimates from population-based clinically-validated data, and (b) test for differences in incidence estimates from
multiple administrative data case definitions.
Methods: Thirty-five case definitions for incident fractures of the hip, wrist, humerus, and clinical vertebrae were
constructed using diagnosis codes in hospital data and diagnosis and service codes in physician billing data from
Manitoba, Canada. Clinically-validated fractures were identified from the Canadian Multicentre Osteoporosis Study
(CaMos). Generalized linear models were used to test for differences in incidence estimates.
Results: For hip fracture, sex-specific differences were observed in the magnitude of under- and over-ascertainment
of administrative data case definitions when compared with CaMos data. The length of the fracture-free period to
ascertain incident cases had a variable effect on over-ascertainment across fracture sites, as did the use of imaging,
fixation, or repair service codes. Case definitions based on hospital data resulted in under-ascertainment of incident
clinical vertebral fractures. There were no significant differences in trend estimates for wrist, humerus, and clinical
vertebral case definitions.
Conclusions: The validity of administrative data for estimating fracture incidence depends on the site and features
of the case definition.
Background
Osteoporosis is a common condition amongst older adults.
It is estimated to affect up to 20% of post-menopausal
women [1]. Monitoring the incidence of osteoporosis-
related fractures is therefore an important component of
a comprehensive population health surveillance system
[2-4]. Administrative data, routinely collected records
used for health system management and physician re-
muneration, are a common tool for population-based
studies about infectious and chronic conditions because
these data contain diagnosis codes for ascertaining dis-
ease cases. Administrative data also contain diagnosis
codes to ascertain fracture cases and have been used in
many countries to study trends in osteoporosis-related
fracture rates [5,6] and risk factors [7,8], and to conduct
pharmaco-epidemiologic investigations about fracture
outcomes [9-11].
The validation studies conducted to date suggest that
administrative data are generally sensitive and specific
for ascertaining cases of hip fracture [12], although this
will vary with the type of hip fracture [13]. Administra-
tive data may lack sensitivity for ascertaining cases of
incident clinical vertebral fracture [14,15]. There has
been limited research about the validity of administra-
tive data for ascertaining cases of other osteoporosis-
related fractures, including fractures of the wrist and
humerus [15,16] . As well, characteristics of the fracture
case definition that may affect the validity of adminis-
trative data for case ascertainment warrant further in-
vestigation. Curtis et al. [14] reported that an incident
clinical vertebral fracture case definition based on
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http://www.biomedcentral.com/1471-2458/12/301hospital diagnoses had a positive predictive value (PPV)
of 91%. A case definition based on diagnoses in a broad
set of administrative databases, including hospital, phys-
ician billing, and emergency room data, had a PPV of
only 46%. Their recommended case definition, which
was based on a diagnosis in physician data in combination
with a spinal imaging test or a diagnosis in hospital data,
had a PPV of 61%. Case definition characteristics that
have varied across studies include the administrative
data source, diagnosis codes, use of codes for fracture-
related services or procedures, and the length of the
fracture-free period to ascertain incident cases [17-19].
The purpose of this study was to investigate administra-
tive data case definitions for osteoporosis-related fractures.
The specific objectives were to: (a) compare the incidence
estimates obtained from administrative data with estimates
obtained from population-based clinically-validated data,
and (b) test for differences in the incidence estimates from
multiple administrative data case definitions.
Methods
Data sources
Administrative data were from the central Canadian
province of Manitoba, which has a population of ap-
proximately 1.2 million. Like other Canadian provinces,
Manitoba has a system of universal healthcare. The
Manitoba Centre for Health Policy Research Data Re-
pository houses computerized databases that contain
records of virtually all contacts with the health care sys-
tem. The databases can be linked via an anonymized
personal identification number. Ethics approval for this
research was received from the Manitoba Health Re-
search Ethics Board and permission to access the study
data was provided by the Manitoba Health Information
Privacy Committee.
Hospital and physician billing claims data were used
to construct the fracture case definitions. Diagnoses in
hospital data are recorded using the International Clas-
sification of Diseases, 9
th revision, Clinical Modification
(i.e., ICD-9-CM), up to and including the 2003/04 fiscal
year (a fiscal year runs from April 1 to March 31) and
the International Classification of Diseases, 10
th revi-
sion, Canadian version (i.e., ICD-10-CA), for subsequent
years. A maximum of 16 ICD-9-CM codes and 25 ICD-
10-CA codes are recorded on each record. Physicians
who are paid on a fee-for-service basis submit billing
claims to the provincial health ministry; these claims
capture almost all outpatient services, including those
provided in hospital emergency and outpatient depart-
ments. While a small percentage of physicians are salaried
(i.e., about 7% of family physicians [20], approximately
90% submit parallel billing claims for administrative
purposes. Physician billing claims contain a single ICD-
9-CM code as well as service codes, which are defined in
a fee schedule (manitoba.ca/health/manual). Diagnosis
codes in hospital and physician data have been validated
and used extensively in Manitoba [21-23] and in other
Canadian jurisdictions [24] for research about chronic
conditions, and they have been used in multiple studies
about osteoporosis-related fractures [9,11,25].
Validation data were from the Canadian Multicentre
Osteoporosis Study (CaMos) [26]. CaMos is an ongoing,
population-based cohort study designed to provide na-
tional estimates of the prevalence and incidence of
osteoporosis and osteoporosis-related fractures. The
study population is composed of non-institutionalized
individuals who reside within a 50-km radius of one of
nine study centres located across Canada. These geo-
graphic areas encompass approximately 40% of the
Canadian population and include both rural and urban
residents. Households in each area were selected by
random draws of listed telephone numbers; one ran-
domly selected household member greater than 25 years
was asked to participate. A total of 9423 participants
entered the study (2884 males and 6539 females) during
the 18-month recruitment period. The characteristics
of study participants have been described previously
[27,28]. A refusal questionnaire was used to assess selec-
tion bias. For osteoporosis prevalence, the primary study
outcome, selection bias was not observed in any of the
study age groups, with the exception of a small amount
of bias in the 80+ age group [29]. Informed consent
was obtained from participants and the study received
approval from the institutional review board at each
participating centre. Data on incident fractures was
compiled from CaMos participants for the period from
1996 to 2006. These data were collected using annual
postal questionnaires and/or in-person interviews [27].
A detailed interviewer-administered questionnaire was
used at years 3, 5, and 10. At baseline, year 5, and year
10, lateral lumbar and thoracic spine X-rays and bone
mineral density tests were performed. At years 1, 2, 4,
and 6 through 9, a detailed two-page questionnaire was
mailed to participants asking about hospitalizations and
fractures within the past year. Participants who reported
having a fracture were asked to provide consent for study
staff to collect additional data about the fracture diagno-
sis from the treating physician and/or hospital record
(i.e., verification by radiology report). We limited the study
to fractures occurring in individuals 50 years of age and
older, with age defined at the fracture index date.
Fracture case definitions
Table 1 lists the 35 administrative data case definitions
that were selected for investigation. These were selected
based on a review of published studies [3,12,30], recom-
mendations from clinical co-investigators with expertise in
fracture ascertainment in administrative databases (WDL,
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other chronic diseases, include osteoporosis, in administra-
tive data [31-33]. The case definitions were differentiated
by: (a) source of data, (b) number of records with the
relevant diagnosis code(s), (c) type of diagnosis in hos-
pital data, (d) presence of service codes in physician
Table 1 Osteoporosis-related fracture case definitions
Case def # of DX & Data source DX codes MR versus any DX Service codes Fracture-free period
(months)
Hip
H1 1 H ICD-9: 820–821; ICD-10: S72.0-S72.2 MR No 0
H2 1 H ICD-9: 820; ICD-10: S72.0-S72.2 MR No 0
H3 1 H same as H2 MR No 6
H4 1 H same as H2 MR No 12
H5 1 H same as H2 Any No 0
H6 1 H same as H2 Any No 6
H7 1 H same as H2 Any No 12
H8 1 H same as H2 MR Yes 0
H9 1 H same as H2 MR Yes 6
H10 1 H same as H2 MR Yes 12
H11 1 H same as H2 Any Yes 0
H12 1 H same as H2 Any Yes 6
H13 1 H same as H2 Any Yes 12
Wrist
W1 1 H or 1 P ICD-9: 813; ICD-10: S52 Any Yes 0
W2 1 H or 1 P same as W1 Any Yes 6
W3 1 H or 1 P same as W1 Any No 6
W4 1 H or (2+ P in 90 days) same as W1 Any Yes 6
W5 1 H or (2+ P in 90 days) same as W1 Any No 6
W6 1 H or (2+ P in 90 days) same as W1 MR Yes 6
W7 1 H or (2+ P in 90 days) same as W1 MR No 6
Humerus
U1 1 H or 1 P ICD-9: 812; ICD-10: S42.2 MR No 0
U2 1 H or 1 P same as U1 MR No 6
U3 1 H or 1 P same as U1 Any No 0
U4 1 H or 1 P same as U1 Any No 6
U5 1 H or (2+ P in 90 days) same as U1 MR No 6
U6 1 H or (2+ P in 90 days) same as U1 Any No 6
U7 1 H or (2+ P in 90 days) same as U1 Any No 12
Clinical vertebral
V1 1 H ICD-9: 805; ICD-10: S22.0, S22.1, S32.0 MR No 0
V2 1 H same as V1 Any No 0
V3 1 H or 1 P same as V1 MR Yes 0
V4 1 H or 1 P same as V1 Any No 0
V5 1 H or 1 P same as V1 Any No 12
V6 1 H or 1 P same as V1 MR No 12
V7 1 H or (2+ P in 90 days) same as V1 MR No 12
V8 1 H or (2+ P in 90 days) same as V1 MR No 12
Note: DX=diagnosis; H=hospital record; P=physician billing claim; MR=most responsible or primary diagnosis in hospital records; A listing of the service codes
used for incident fracture ascertainment is provided in the Appendix.
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period. With the exception of one hip fracture case def-
inition, all site-specific definitions used the same ICD-
9-CM and ICD-10-CA diagnosis code(s). For hip frac-
ture, we considered ICD-9-CM 820 (fracture of neck of
the femur) and 821 (fracture and other unspecified parts
of the femur) because some hip fractures may be
assigned a less precise diagnosis code [34]. Case defini-
tions were based on hospital data only (hip) or hospital
and physician claims data, in keeping with previous re-
search [3,15]. For the latter, case definitions requiring
one or at least two records with the specified diagnosis
code(s) were considered. Service codes capture radio-
logic and magnetic resonance imaging services for inci-
dent clinical vertebral fracture, immobilization or
fixation services for wrist fracture, and surgical repair
and fixation procedures for hip fracture. Service codes
have also been used in previous studies to improve frac-
ture ascertainment [35]. Fracture-free periods of zero,
six or twelve months were considered, using the site-
specific fracture index date to establish the end-point of
the fracture-free period.
To illustrate the interpretation of the case definitions,
H1 identifies hip fractures using hospital records with
ICD-9-CM 820 or 821 (ICD-10-CA S72.0, S72.1, or S72.2)
as the most responsible (i.e., primary) diagnosis; it does
not use physician service codes nor does it require a
fracture-free period. In contrast, case definition H13
identifies hip fractures from hospital records with
ICD-9-CM 820 (ICD-10-CA S72.0, S72.1, or S72.2) in
any diagnosis field. A physician service code was present
within the hospitalization period and a 12-month fracture-
free period was adopted. For wrist fracture, case definition
W1 identifies fractures using hospital or physician billing
records with ICD-9-CM 813 (ICD-10-CA S52) in any
diagnosis field. This case definition requires a physician
service code to accompany the diagnosis code and does
not adopt a fracture-free period.
The fracture index date was the date of the first diagno-
sis or service code for a fracture event. Pathologic fractures
were included because they represent a small proportion
of all fractures and their exclusion can lead to underesti-
mation of the fracture burden due to osteoporosis [36].
For each case definition, the number of incident fractures
was generated for the Manitoba population 50 years of age
and older for fiscal years 1997/98 to 2006/07. Age, which
was defined using the fracture index date, was obtained
from health insurance registration files. For hip fracture,
counts of incident fractures were generated both including
and excluding residents of long-term care (i.e., nursing
home) facilities [37]; the CaMos data excludes residents of
these facilities and this may affect comparability of esti-
mates. Residence in a facility was determined from nursing
home files containing admission and separation dates.
Statistical analyses
Crude and sex- and age-specific fracture rates were cal-
culated for administrative case definitions and for the
CaMos data. Generalized linear models (GLMs) were
used to test for differences in the estimates from admin-
istrative and CaMos data [38]. For each case definition,
sex-specific models that contained the main effects of
age (five-year groupings from 50–54 years to 80+ years)
and source (i.e., administrative; reference: CaMos) were
fit to the data, along with a model that combined the
data for males and females; this latter model contained
the main effects of age, source, and sex. A negative bino-
mial distribution was adopted to model the data due to
the presence of extra-Poisson variation in the case
counts. Fit was evaluated using the ratio of model devi-
ance to degrees of freedom, which should be close to
one for a well-fitted model. A Wald χ
2 statistic was used
to test the difference in the estimates from administrative
and CaMos data. Each test was conducted at the α=.01
significance level in order to control the familywise error
rate, the probability of committing at least one Type I
error. The relative rate (RR) of incident fractures for ad-
ministrative data case definitions was obtained by expo-
nentiation of the regression coefficient for the source
variable.
GLMs with generalized estimating equations were used
to test for differences among the case definitions [39].
Annual fracture counts (i.e., for 1997/98 to 2006/07) for
population strata defined by age (five-year groupings
from 50–54 years to 85+ years) and sex were modeled
assuming a negative binomial distribution. An exchange-
able structure, which assumes constant correlation in
successive years, accounted for dependence among the
incident fracture counts. Models containing the main
effects of age group, case definition, sex, year, and the
year x case definition interaction were fit to the data for
each fracture site. The interaction was used to test for
differences in the linear trend across case definitions. If
the interaction was statistically significant, linear con-
trasts were used to test for differences amongst selected
pairs of case definitions. A significance level of α=.05
was adopted for the omnibus test and each of the con-
trast tests was conducted at α=.01. If the interaction
was not significant, the main effects of year and case def-
inition were investigated.
Results
Age-specific and overall fracture incidence estimates
from the CaMos data are reported for males and females
in Table 2. There were 65905 person years of observation
and 875 clinically-recognized incident osteoporosis-
related fractures verified in the study period. Of this
number, 22.6% were hip, 41.3% were wrist, 13.6% were
humerus, and 22.5% were clinical vertebral fractures.
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were more than three million person years of observation.
RR estimates and tests of differences in adjusted incidence
estimates for the CaMos and administrative data are
reported in Table 3. For hip fractures, when the data for
both sexes were combined and long-term care residents
were included, case definitions H5, H6, and H7 resulted
in RR estimates that were significantly greater than the
CaMos estimates (i.e., over-ascertainment), while the
remaining case definitions did not result in significantly
different estimates. For females, all case definitions except
for H8, H9, and H10 resulted in over-ascertainment of
hip fracture rates. For males, these three case definitions
resulted in RR estimates that were significantly lower than
the CaMos estimates (i.e., under-ascertainment).
Subsequent analyses of the hip fracture data when
long-term care residents were excluded revealed similar
RR estimates to those reported in Table 3. For example,
when the data for males and females were combined,
case definitions H5 (RR=1.44; p<.0001), H6 (RR=1.39;
Table 2 CaMos Osteoporosis-related incident fracture
rates per 100,000 person years (95% confidence
intervals)
Age group Males Females
Hip
50-59 33.0 (0.0, 97.6) 29.4 (0.0, 79.1)
60-69 132.4 (31.5, 233.3) 63.4 (0.0, 159.7)
70-79 239.1 (116.0, 362.3) 309.6 (230.4, 388.9)
80+ 950.2 (717.2, 1183.2) 1079.1 (928.1, 1230.1)
All Ages 272.6 (143.5, 401.6) 310.9 (54.0, 567.8)
Wrist
50-59 197.9 (39.7, 356.1) 308.6 (147.7, 469.5)
60-69 115.9 (21.5, 210.3) 615.4 (316.6, 914.3)
70-79 223.2 (104.2, 342.2) 855.7 (724.3, 914.3)
80+ 228.1 (113.5, 342.6) 763.3 (636.0, 890.5)
All Ages 183.6 (77.6, 289.5) 684.4 (303.9, 1064.8)
Humerus
50-59 33.0 (0.0, 97.6) 29.4 (0.0, 79.1)
60-69 82.8 (3.0, 162.6) 184.0 (20.2, 347.8)
70-79 95.6 (17.7, 173.6) 242.1 (172.0, 312.2)
80+ 228.1 (113.5, 342.6) 644.8 (527.8, 761.8)
All Ages 100.1 (21.9, 178.4) 256.6 (23.2, 490.1)
Clinical vertebral
50-59 164.9 (20.5, 309.3) 176.3 (54.7, 298.0)
60-69 115.9 (21.5, 210.3) 152.3 (3.3, 301.3)
70-79 207.2 (92.6, 321.9) 394.1 (304.7, 483.4)
80+ 304.1 (171.8, 436.3) 763.3 (636.0, 890.5)
All Ages 183.6 (77.6, 289.5) 342.2 (72.7, 611.7)
Table 3 Relative Rates (RRs) of osteoporosis-related
incident fractures in administrative data using CaMos as
the reference
Case def Both sexes Females Males
RR p-value RR p-value RR p-value
Hip
H1 1.21 .0318 1.40 <.0001 0.89 .4295
H2 1.14 .1408 1.31 .0008 0.85 .2542
H3 1.11 .2567 1.27 .0028 0.83 .1931
H4 1.10 .2963 1.26 .0045 0.82 .1813
H5 1.50 <.0001 1.73 <.0001 1.12 .4481
H6 1.45 <0001 1.67 <.0001 1.08 .5837
H7 1.43 <0001 1.64 <.0001 1.07 .5235
H8 0.94 .4874 1.08 .3160 0.68 .0083
H9 0.93 .4322 1.07 .3837 0.68 .0074
H10 0.93 .3863 1.06 .4626 0.68 .0069
H11 1.23 .0167 1.42 <.0001 0.89 .4112
H12 1.22 .0205 1.41 <.0001 0.88 .3887
H13 1.21 .0238 1.39 <.0001 0.88 .3695
Wrist
W1 1.15 .0731 1.17 .0055 1.06 .7176
W2 0.69 <.0001 0.71 <.0001 0.66 .0162
W3 1.02 .7420 1.03 .6599 1.06 .7502
W4 0.62 <.0001 0.63 <.0001 0.58 .0015
W5 0.77 .0005 0.78 <.0001 0.73 .0671
W6 0.56 <.0001 0.57 <.0001 0.50 <.0001
W7 0.72 <.0001 0.73 <.0001 0.67 .0189
Humerus
U1 4.33 <.0001 4.44 <.0001 4.15 <.0001
U2 1.20 .0473 1.24 .0166 1.17 .4913
U3 4.42 <.0001 4.53 <.0001 4.23 <.0001
U4 1.24 .0198 1.28 .0059 1.20 .4082
U5 0.85 .0744 0.88 .1470 0.77 .2521
U6 0.91 .2899 0.94 .4870 0.83 .3973
U7 0.90 .2143 0.92 .3769 0.81 .3600
Clinical vertebral
V1 0.10 <.0001 0.09 <.0001 0.14 <.0001
V2 0.17 <.0001 0.16 <.0001 0.25 <.0001
V3 0.28 <.0001 0.28 <.0001 0.33 <.0001
V4 1.70 <0001 1.70 <.0001 2.06 <.0001
V5 0.79 .0111 0.80 .0057 0.92 .6249
V6 0.75 .0020 0.77 .0007 0.86 .3884
V7 0.18 <.0001 0.18 <.0001 0.21 <.0001
V8 0.33 <.0001 0.33 <.0001 0.41 <.0001
Note: bold values are statistically significant at α=.01; See Table 1 for a
description of the case definitions.
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ascertainment of hip fracture rates.
For wrist fractures, most definitions resulted in under-
ascertainment of fracture rates except for W1 and W3 in
the combined and female populations and W4 and W6
in the male population. Among the seven definitions
investigated for humerus fractures, U1 and U3 over-
ascertained incidence rates in the combined, female, and
male populations while the remaining case definitions
did not result in significant differences from the CaMos
data. Of the eight case definitions investigated for inci-
dent clinical vertebral fracture; six resulted in under-
ascertainment in the overall and male populations and
seven resulted in under-ascertainment in the female popu-
lation. One case definition resulted in over-ascertainment
and one resulted in no significant difference from the
CaMos data in the combined population.
Crude annual fracture rates, stratified by sex, for the case
definitions selected as the references for the GEE models,
H2, W1, U2, and V5 are reported in Figure 1. These case
definitions resulted in the identification of 81187 incident
fractures in the study period, of which 26.2% were hip,
39.4% were wrist, 18.2% were humerus, and 16.2% were
vertebral fractures. The year x definition interaction was
statistically significant for hip (p<.0001), but not for wrist
(p=.4259), humerus (p=.3515),andvertebrae(p=.0865).
For hip fracture, while H2 showed an average annual
decrease of 4.1%, six case definitions resulted in smaller
estimates of decline over time (p<.01): H4, H5, H6, H11,
H12, and H13.
Tests of the year main effect revealed a decreasing
trend for wrist (p<.0001), an increasing trend for verte-
bral (p=.0012), and no statistically significant change for
humerus (p=.2226). For wrist fractures, all case defini-
tions with the exception of W3 resulted in incidence esti-
mates that were significantly lower than then reference
definition (p<.0001). For humerus fractures, all case defi-
nitions resulted in incidence estimates that were signifi-
cantly different from the reference definition (p<.0001)
with the exception of U4 (p=.2315). The same finding was
observed for vertebral fractures with the exception of V6
(p=.0555).
Discussion
This study adopted a population-based methodology
to assess the validity of multiple case definitions for
Figure 1 Trends in Crude Osteoporosis-Related Incident Fracture Rates for Selected Administrative Data Case Definitions, 1997/98 – 2006/07.
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administrative data. Fracture rates estimated from hos-
pital and physician billing claims data were compared
to clinically-validated fracture estimates obtained from
a representative sample of the Canadian population. In
addition, estimates from multiple administrative data
case definitions were compared over time.
For hip fracture, the magnitude of under- or over-
ascertainment compared to CaMos data was modest
regardless of the choice of case definitions. This sug-
gests that administrative data are a valid data source
for ascertaining cases of hip fracture, which is consist-
ent with the findings of previous studies [3,15,40].
However, there were sex-specific differences in the
magnitude of over- or under-ascertainment. Only three
hip case definitions did not result in over-ascertainment
in females. For males, these same case definitions resulted
in under-ascertainment of fracture rates. We hypothesize
that sex-specific differences in hip fracture inpatient treat-
ment, which have been attributed to differences in comor-
bidity characteristics of males and females at the time of
hip fracture [41], contributed to these findings. Alterna-
tively, there may be sex-specific differences in the report-
ing of hip fracture in the CaMos data.
The magnitude of the RR estimates for wrist, humerus,
and vertebrae case definitions were generally similar for
males and females, suggesting there may be fewer differ-
ences in the treatment of these fractures in the health
care system. Case definitions that required a diagnosis
in two or more physician claims often resulted in
under-ascertainment of wrist fractures. For chronic con-
ditions such as diabetes and inflammatory bowel disease,
the presence of a single diagnosis code may indicate an
attempt by a physician to ‘rule-out’ the condition in a
patient [23] and produce a case definition with an excess
of false positives. However, this rule-out effect does not
appear to be evident for fractures, indicating that indivi-
duals may not have multiple visits to physicians with a
diagnosis code for one of these fractures. The amount of
over-ascertainment of fracture rates when a fracture-free
period for incident cases was not adopted varied with
the fracture site; it was large for humerus and vertebrae
fractures but small for wrist fractures. For incident clin-
ical vertebral fractures, the study findings are consistent
with previous research showing that fractures may be
under-ascertained in administrative data [14], even if
both hospital and physician data are used to construct
the case definition. Health care professionals in both in-
patient and out-patient settings cannot reliably diagnose
these fractures.
The magnitude of change in incidence estimates over
time varied across the case definitions for hip, but not for
the remaining fracture sites. Further investigation revealed,
however, that this difference was not due to the transition
from ICD-9-CM to ICD-10-CA coding in hospital data.
When we tested the sex-specific differences in the rate
of change in hip fracture estimates before and after the
introduction of ICD-10-CA, no statistically significant
differences (p<.01) were observed.
This study has some limitations. Fracture case defini-
tions were not validated using medical chart review, a
method that has been recommended and used in previ-
ous studies [14]. Chart-based validation of fracture case
definitions based on both hospital and physician claims
databases would be difficult in Manitoba’s universal health
care system because patients may receive care from more
than one clinic, facility, or physician group, which could
potentially result in multiple charts. Also, chart review
may result in low power to validate case definitions in
population sub-groups and for low-incidence events and
the generalizability of the findings will be influenced by
the method of sample selection. A second limitation is
that we compared aggregate fracture estimates and tested
whether there was a significant difference between the
administrative data case definitions and the CaMos case
definitions rather than whether they were equivalent. A
test of statistical equivalence may have been preferred,
but to our knowledge, no such test has been developed
for count data [42]. The appropriateness of using CaMos
data as a reference standard for evaluating the validity
o ff r a c t u r ec a s ed e f i n i t i o n sm a yb eq u e s t i o n e d ,b e c a u s e
the sample represents the Canadian population but not
necessarily the Manitoba population. However, previ-
ous research has demonstrated that for hip fracture,
Manitoba incidence estimates do not differ from national
estimates [43]. Furthermore, self-report instruments have
been shown to result in under-ascertainment of hip frac-
tures when compared to administrative data [30,44].
Virnig et al. found that patient factors such as living
with others, and mental status as identified from the
mini-mental status exam score, and being unable to
stand without using one’s arms were associated with a
false negative hip fracture self-report [44]. However, it
is important to note that CaMos uses both self- and
interviewer-administered instruments to capture com-
prehensive information on fracture history.
Conclusions
In summary, a number of recommendations for ascertain-
ing osteoporosis-related fractures from administrative data
arise from this study. For hip fractures, different case defi-
nitions for females and males might be considered, with a
primary diagnosis of hip fracture and service codes recom-
mended for ascertaining female cases. For wrist fractures,
service codes should be used to construct the case defin-
ition. For both humerus and clinical vertebral fractures,
the use of a fracture-free period is important to ascertain
incident events. Overall, ascertainment of incident fracture
Lix et al. BMC Public Health 2012, 12:301 Page 7 of 10
http://www.biomedcentral.com/1471-2458/12/301cases does not require the use of more than one record
with the relevant diagnosis code. The findings demonstrate
that administrative data are generally useful for establish-
ing a surveillance program about osteoporosis-related
fracture.
Appendix: Physician service codes used to identify
osteoporosis-related fracture cases
A. Services codes used to identify hip fractures
0865: fractures, lower extremity, femur, neck, closed re-
duction, cast or traction
0868: fractures, lower extremity, femur, neck, open re-
duction with internal fixation
0870: fractures, lower extremity, femur, neck, prosthetic
replacement
0872: fractures, lower extremity, intertrochanteric, closed
reduction
0874: fractures, lower extremity, intertrochanteric, open
reduction
1149: joints, anthroplasty, hip, femoral head replacement
type
1150: joints, arthroplasty, hip (cup or total hip replace-
ment prosthesis)
1154: joints, arthroplasty, hip, femoral head, where previ-
ous prosthesis, etc. require removal
B. Service codes used to identify wrist fractures
0807: fractures, upper extremity, distal end, closed
reduction
0810: fractures, upper extremity, distal end, open reduction
0811: fractures, upper extremity, distal end, skeletal pinning
0821: fractures, upper extremity, radius and ulna, closed
reduction
1851: plaster casts, forearm
1854: plaster casts, elbow to fingers
1856: plaster casts, hand to wrist
1860: plaster casts, shoulder to hand
C. Service codes used to identify incident clinical
vertebral fractures
7025: radiology, chest, posteroanterior and lateral
7035: radiology, spine and pelvis, spine, complete
7036: radiology, spine and pelvis, cervical spine, routine
views
7037: radiology, spine and pelvis, spine, 2 full areas
7039: radiology, spine and pelvis, pelvis, anteroposterior
view
7041: radiology, spine and pelvis, sacroiliac joints
7054: radiology, lumbo-sacral, routine views with special
added views (obliques and/or flexion)
7061: radiology, spine and pelvis, single combining re-
gion (thoraco-lumbar)
7193: radiology, spine and pelvis, lumbo-sacral, routine
views
7194: radiology, spine and pelvis, thoracic spine
7224: radiology, computerized axial tomography thorax
exam
7225: radiology, computerized axial tomography abdomen
and/or pelvis exam
7228: radiology, computerized axial tomography spine-
thoracic exam
7229: radiology, computerized axial tomography spine-
lumbar exam
7331: radiology, chest, ribs, both sides
7332: radiology, chest, thoracic inlet, two views
7339: radiology, spine and pelvis, pelvis with lateral hip
joint
7341: radiology, skeletal survey (thorax, skull, thoracic
and lumbar spine, pelvis, long bones)
7402: radiology, spine and pelvis, special views (minimum
two views)
7519: MRI, limited spine, one segment multi-slice t2
(one or two echoes)
7520: MRI, limited spine one segment multi-slice i.r. or
t1
7521: MRI, limited spine one segment repeat (another
plane, different pulse sequence to a max of two repeats)
7522: MRI, intermediate, spine, 2 adjoining segments
multi-slice t2 (one or two echoes)
7523: MRI, intermediate, spine, two adjoining segments
multi-slice i.r. or t1
7524: MRI, intermediate spine, two adjoining segment
repeat (add plane, different pulse sequence, maximum
two repeats)
7525: MRI, complex spine, two or more non-adjoining
segments, multi-slice t2 (1 or 2 echoes)
7526: MRI, complex spine, two or more non-adjoining
segments, multi-slice i.r. or t
7527: MRI, complex spine, two or more non-adjoining
segment repeat (add plane, different pulse sequence,
maximum two repeats)
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